Funding
Undisclosed · Biotech

Axol Bioscience raises $2.8M financing

Axol Bioscience raised $2.8 million in financing announced in January.

Updated Oct 16, 2026By RoundOS Funding desk

BroadOak Capital Partners and the Roslin Foundation are among its backers. The round stage was not disclosed.

The company provides human induced pluripotent stem-cell technologies.

Funding history

Undisclosed · This round$2.8M

Sources

  1. Axol Bioscienceprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related